ArticleMolecular cancer research : MCR2023

Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors.

Sarah E Fenton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.